|
Celator Pharmaceuticals Announces Pricing Of A $12.9M Public Offering Of …
Benzinga Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … |
